• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物性胸痛与心肌梗死。向国家中心提交的报告及文献综述。

Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature.

作者信息

Ottervanger J P, Wilson J H, Stricker B H

机构信息

Department of Internal Medicine II, University Hospital Dijkzigt, Rotterdam, The Netherlands.

出版信息

Eur J Clin Pharmacol. 1997;53(2):105-10. doi: 10.1007/s002280050346.

DOI:10.1007/s002280050346
PMID:9403280
Abstract

OBJECTIVES

To analyse reports of drug-induced myocardial infarction and chest pain sent to a national reporting centre. To review which drugs were suspected of exhibiting these adverse events and what mechanisms were involved.

METHODS

During the 20-year period 1975 through 1994, a total of 19,141 reports on adverse reactions to drugs were received by the Netherlands Centre for Monitoring of Adverse Reactions to Drugs. Of these 19,141 reports, 220 (1.1%) were concerned with drug-induced chest pain or myocardial infarction. After excluding reports in which the causal relationship was unlikely, poorly documented reports and reports on cases of overdosage, 183 reports (84%) were analysed.

RESULTS

There were 130 reports (71%) of drug-induced chest pain and 53 reports (29%) of drug-induced myocardial infarction. A total of 104 reports concerned females (57%). The most frequently reported suspected drugs were the antimigraine drug sumatriptan (33 reports, 4 concerning myocardial infarction), the calcium antagonist nifedipin (9 reports, 2 of myocardial infarction) and nicotine [9 reports (8 patches, 1 chewing gum), 5 concerning myocardial infarction]. There were 18 reports of a fatal outcome.

CONCLUSIONS

Several drugs can produce chest pain or myocardial ischaemia. It is important to recognise drugs as a potential cause, especially in patients with normal coronary arteries.

摘要

目的

分析发送至国家报告中心的药物性心肌梗死和胸痛报告。回顾哪些药物被怀疑引发了这些不良事件以及涉及哪些机制。

方法

在1975年至1994年的20年期间,荷兰药物不良反应监测中心共收到19141份药物不良反应报告。在这19141份报告中,220份(1.1%)涉及药物性胸痛或心肌梗死。排除因果关系不太可能、记录不充分的报告以及过量用药病例报告后,对183份报告(84%)进行了分析。

结果

有130份(71%)药物性胸痛报告和53份(29%)药物性心肌梗死报告。共有104份报告涉及女性(57%)。报告中最常被怀疑的药物是抗偏头痛药物舒马曲坦(33份报告,4份涉及心肌梗死)、钙拮抗剂硝苯地平(9份报告,2份涉及心肌梗死)和尼古丁[9份报告(8份为贴片,1份为口香糖),5份涉及心肌梗死]。有18份报告出现了致命结局。

结论

几种药物可导致胸痛或心肌缺血。认识到药物是潜在病因很重要,尤其是在冠状动脉正常的患者中。

相似文献

1
Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature.药物性胸痛与心肌梗死。向国家中心提交的报告及文献综述。
Eur J Clin Pharmacol. 1997;53(2):105-10. doi: 10.1007/s002280050346.
2
Characteristics and determinants of sumatriptan-associated chest pain.舒马曲坦相关性胸痛的特征与决定因素。
Arch Neurol. 1997 Nov;54(11):1387-92. doi: 10.1001/archneur.1997.00550230054017.
3
Adverse reactions attributed to sumatriptan. A postmarketing study in general practice.
Eur J Clin Pharmacol. 1994;47(4):305-9. doi: 10.1007/BF00191159.
4
Nifedipine--a survey of adverse effects. Four years' reporting in Sweden.硝苯地平——不良反应调查。瑞典四年的报告情况
Acta Pharmacol Toxicol (Copenh). 1986;58 Suppl 2:133-6. doi: 10.1111/j.1600-0773.1986.tb02528.x.
5
[Chest pain due to sumatriptan].[舒马曲坦所致胸痛]
Ned Tijdschr Geneeskd. 1992 Sep 5;136(36):1774-6.
6
Dihydroergotamine-induced vasospastic angina in a patient taking a calcium channel blocker.服用钙通道阻滞剂的患者出现二氢麦角胺诱发的血管痉挛性心绞痛。
Ann Pharmacother. 2011 Jul;45(7-8):e41. doi: 10.1345/aph.1P776. Epub 2011 Jun 21.
7
Coronary side-effect potential of current and prospective antimigraine drugs.当前及未来抗偏头痛药物的冠状动脉副作用可能性
Circulation. 1998 Jul 7;98(1):25-30. doi: 10.1161/01.cir.98.1.25.
8
Coronary vasospasm and myocardial infarction induced by oral sumatriptan.口服舒马曲坦诱发的冠状动脉痉挛和心肌梗死
Clin Neuropharmacol. 2004 Jul-Aug;27(4):198-200. doi: 10.1097/01.wnf.0000136889.78887.6f.
9
Safety of nifedipine GITS in stable angina: the ACTION trial.硝苯地平控释片治疗稳定型心绞痛的安全性:ACTION试验
Cardiovasc Drugs Ther. 2006 Feb;20(1):45-54. doi: 10.1007/s10557-006-6312-4.
10
[Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993].[药品不良反应监测局对疑似不良反应的登记;1993年的研究活动]
Ned Tijdschr Geneeskd. 1994 Oct 15;138(42):2110-3.

引用本文的文献

1
Doxorubicin alters G-protein coupled receptor-mediated vasocontraction in rat coronary arteries.多柔比星改变大鼠冠状动脉中 G 蛋白偶联受体介导的血管收缩。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5831-5845. doi: 10.1007/s00210-024-02988-x. Epub 2024 Feb 8.
2
Acute Chest Pain as an Infusion Reaction to Vedolizumab.急性胸痛作为维多珠单抗的输液反应
Case Rep Gastroenterol. 2022 Jun 28;16(2):430-434. doi: 10.1159/000525404. eCollection 2022 May-Aug.
3
Vasospasm induced myocardial ischaemia secondary to sumatriptan use.
舒马曲坦使用导致的血管痉挛性心肌缺血。
BMJ Case Rep. 2020 Aug 24;13(8):e235387. doi: 10.1136/bcr-2020-235387.
4
Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).观察性医疗结局合作组织(OMOP)将药物-事件关联错误分类为金标准“阴性对照”的证据。
Drug Saf. 2016 May;39(5):421-32. doi: 10.1007/s40264-016-0392-2.
5
A novel effect of Noscapine on patients with massive ischemic stroke: A pseudo-randomized clinical trial.诺司卡品对大面积缺血性脑卒中患者的一种新作用:一项伪随机临床试验。
Iran J Neurol. 2015 Jan 5;14(1):12-6.
6
Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries.
Eur J Clin Pharmacol. 2005 Nov;61(10):733-42. doi: 10.1007/s00228-005-0988-4. Epub 2005 Sep 8.
7
Tolerability of the triptans: clinical implications.曲坦类药物的耐受性:临床意义。
Drug Saf. 2003;26(2):93-107. doi: 10.2165/00002018-200326020-00003.
8
Initial Abortive Treatments for Migraine Headache.偏头痛的初始急救治疗
Curr Treat Options Neurol. 2002 Sep;4(5):343-350. doi: 10.1007/s11940-002-0044-y.
9
Atrial fibrillation associated with sumatriptan.与舒马曲坦相关的心房颤动。
BMJ. 2000 Jul 29;321(7256):275. doi: 10.1136/bmj.321.7256.275.
10
No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.5-HT1D和5-HT1F受体激动剂对人和牛脑动脉无收缩作用:与人类冠状动脉相似。
Br J Pharmacol. 2000 Feb;129(3):501-8. doi: 10.1038/sj.bjp.0703081.